Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.

Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis. PLoS One (2016) 0.75

Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients. Onco Targets Ther (2017) 0.75

Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22

Index for rating diagnostic tests. Cancer (1950) 27.09

Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci U S A (2004) 7.55

Lung cancer. Lancet (2000) 3.93

Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta (1999) 3.17

Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer (2004) 2.30

Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma. J Proteome Res (2009) 2.20

Clinical practice. Lung cancer screening. N Engl J Med (2005) 2.19

Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors. Tumour Biol (2003) 1.69

Proteomic and cytokine plasma biomarkers for predicting progression from colorectal adenoma to carcinoma in human patients. Proteomics (2013) 1.66

The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res (Phila) (2012) 1.49

Sample handling for mass spectrometric proteomic investigations of human sera. Anal Chem (2005) 1.23

Early diagnosis of lung cancer by detection of tumor liberated protein. J Cell Physiol (2005) 1.14

Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer. J Proteome Res (2011) 1.08

An antitumour lectin from the edible mushroom Agrocybe aegerita. Biochem J (2003) 1.07

Identification of candidate biomarkers for early detection of human lung squamous cell cancer by quantitative proteomics. Mol Cell Proteomics (2012) 1.04

Lectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers. J Proteome Res (2012) 1.01

Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results? Br J Cancer (1995) 1.01

The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma. Cancer (1988) 0.99

Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens. Cancer Res (2009) 0.97

A novel lectin from Agrocybe aegerita shows high binding selectivity for terminal N-acetylglucosamine. Biochem J (2012) 0.96

Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer. Mol Cell Proteomics (2013) 0.96

Serum tumour markers in lung cancer: history, biology and clinical applications. Eur Respir J (1994) 0.95

A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma. J Proteomics (2012) 0.95

Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery. Mass Spectrom Rev (2012) 0.94

The "old" Euonymus europaeus agglutinin represents a novel family of ubiquitous plant proteins. Plant Physiol (2008) 0.94

Alpha-1-antichymotrypsin expression in lung adenocarcinoma and its possible association with tumor progression. Cancer (1995) 0.94

Proteomics in the forefront of cancer biomarker discovery. J Proteome Res (2005) 0.92

Differentially expressed glycosylated patterns of α-1-antitrypsin as serum biomarkers for the diagnosis of lung cancer. Glycobiology (2014) 0.92

Development of an AlphaLISA assay to quantify serum core-fucosylated E-cadherin as a metastatic lung adenocarcinoma biomarker. J Proteomics (2012) 0.91

Fucosylated glycoproteomic approach to identify a complement component 9 associated with squamous cell lung cancer (SQLC). J Proteomics (2011) 0.90

Comparative analysis of the human urinary proteome by 1D SDS-PAGE and chip-HPLC-MS/MS identification of the AACT putative urinary biomarker. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.89

Structural basis for distinct binding properties of the human galectins to Thomsen-Friedenreich antigen. PLoS One (2011) 0.88

Liver proteins as sensor of human malignancies and inflammation. Proteomics Clin Appl (2010) 0.87

Crystallization and preliminary crystallographic studies of the recombinant antitumour lectin from the edible mushroom Agrocybe aegerita. Biochim Biophys Acta (2005) 0.87

Molecular character of the recombinant antitumor lectin from the edible mushroom Agrocybe aegerita. J Biochem (2005) 0.86

Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis. Hepatology (1993) 0.83

Nuclear α1-antichymotrypsin promotes chromatin condensation and inhibits proliferation of human hepatocellular carcinoma cells. Gastroenterology (2013) 0.83

Identification of human complement factor B as a novel biomarker candidate for pancreatic ductal adenocarcinoma. J Proteome Res (2014) 0.81

Lethal protein in mass consumption edible mushroom Agrocybe aegerita linked to strong hepatic toxicity. Toxicon (2014) 0.77

The challenge of classifying poorly differentiated tumours in the lung. Histopathology (2009) 0.77